The use of everolimus to target carcinogenic pathways in a patient with renal cell carcinoma and tuberous sclerosis complex: a case report

INTRODUCTION: An increased understanding of the genetic pathways involved in renal cell carcinoma has resulted in the development of various drugs that target relevant signaling cascades for the specific treatment of this disease. However, no validated predictive markers have been identified to guid...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hye Sook, Kim, Seung Tae, Kang, Seok Ho, Sung, Deuk Jae, Kim, Chul Hwan, Shin, Sang Won, Kim, Yeul Hong, Cho, Won Yong, Park, Kyong Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976165/
https://www.ncbi.nlm.nih.gov/pubmed/24612911
http://dx.doi.org/10.1186/1752-1947-8-95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976165/
https://www.ncbi.nlm.nih.gov/pubmed/24612911
http://dx.doi.org/10.1186/1752-1947-8-95

Ejemplares similares